Angiotensin-Receptor Blockers, Type 2 Diabetes, and Renoprotection

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493 · see citing works

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

(1998) · BMJ · doi:10.1136/bmj.317.7160.703 · Cited by 6,683 · see citing works

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

(1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.21.2413 · Cited by 6,345 · see citing works

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987 · see citing works

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803 · see citing works

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873 · see citing works

[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].

Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,527 · see citing works

Oxidative Stress and Diabetic Vascular Complications

Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,938 · see citing works

Angiotensin II-induced superoxide anion generation in human vascular endothelial cells Role of membrane-bound NADH-/NADPH-oxidases

Zhang, H. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00183-2 · Cited by 296 · see citing works

Angiotensin II induces superoxide anion production by mesangial cells

Jaimes, E. A., Galcerán, J., & Raij, L. R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00068.x · Cited by 271 · see citing works

Are ACE Inhibitors a “Magic Bullet” Against Oxidative Stress?

Münzel, T. F., & Keaney, J. F. (2001) · Circulation · doi:10.1161/hc3801.095585 · Cited by 226 · see citing works

Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.

Ceriello, A., Morocutti, A., Mercuri, F., Quagliaro, L., Moro, M., Damante, G., & Viberti, G. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2170 · Cited by 209 · see citing works

Endothelial Dysfunction and Oxidative Stress During Estrogen Deficiency in Spontaneously Hypertensive Rats

Waßmann, S., Bäumer, A. T., Strehlow, K., van Eickels, M., Grohé, C., Ahlbory, K., Rösen, R., Böhm, M., & Nickenig, G. (2001) · Circulation · doi:10.1161/01.cir.103.3.435 · Cited by 181 · see citing works

Prevention of End-Stage Renal Disease Due to Type 2 Diabetes

Hostetter, T. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200109203451209 · Cited by 169 · see citing works

Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors

Ahuja, T. S., Freeman Jr., D., Mahnken, J. D., Agraharkar, M., Siddiqui, M., & Memon, A. (2000) · American Journal of Nephrology · doi:10.1159/000013599 · Cited by 114 · see citing works

Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited

Ceriello, A., & Motz, E. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000122852.22604.78 · Cited by 1,378 · see citing works

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy

Ceriello, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1589 · Cited by 734 · see citing works

Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients

Ceriello, A., Assaloni, R., Da Ros, R., Maier, A., Piconi, L., Quagliaro, L., Esposito, K., & Giugliano, D. (2005) · Circulation · doi:10.1161/01.cir.0000165070.46111.9f · Cited by 298 · see citing works

Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes

Ceriello, A. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000245256.17764.fb · Cited by 75 · see citing works

Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?

Prattichizzo, F., Giuliani, A., Nigris, V. D., Pujadas, G., Çeka, A., Sala, L. L., Genovese, S., Testa, R., Procopio, A. D., Olivieri, F., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12688 · Cited by 69 · see citing works

Telmisartan Shows an Equivalent Effect of Vitamin C in Further Improving Endothelial Dysfunction After Glycemia Normalization in Type 1 Diabetes

Ceriello, A., Piconi, L., Esposito, K., & Giugliano, D. (2007) · Diabetes Care · doi:10.2337/dc07-0318 · Cited by 47 · see citing works

Effects of Irbesartan on Intracellular Antioxidant Enzyme Expression and Activity in Adolescents and Young Adults With Early Diabetic Angiopathy

Chiarelli, F., Marzio, D. D., Santilli, F., Mohn, A., Blasetti, A., Cipollone, F., Mezzetti, A., & Verrotti, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1690 · Cited by 46 · see citing works

Enalapril reduces germ cell toxicity in streptozotocin-induced diabetic rat: investigation on possible mechanisms

Kushwaha, S., & Jena, G. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0707-x · Cited by 33 · see citing works

Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario

Alter, D. A., Khaykin, Y., Austin, P. C., Tu, J. V., & Hux, J. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1427 · Cited by 33 · see citing works

Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients

Ceriello, A., Assaloni, R., Da Ros, R., Maier, A., Quagliaro, L., Piconi, L., Esposito, K., & Giugliano, D. (2004) · Diabetologia · doi:10.1007/s00125-004-1487-3 · Cited by 24 · see citing works

Oxidative stress detection: what for? Part I.

Palmieri, B., & Sblendorio, V. (2006) · PubMed · Cited by 21 · see citing works

Effects of macronutrient excess and composition on oxidative stress: Relevance to diabetes and cardiovascular disease

Ceriello, A. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0022-z · Cited by 18 · see citing works

Pharmacoeconomic aspects of losartan treatment to delay progression of renal disease in patients with Type 2 diabetes

Postma, M. J., Kruidhof, H., den Berg, L. T. W. D. J., & de Zeeuw, D. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.9.1543 · Cited by 3 · see citing works

INVOLVEMENT OF FREE RADICALS IN CARDIOVASCULAR COMPLICATION IN TYPE 2 DIABETES - A REVIEW

Kakadiya, J., & Township, A. (2009)

Pulmonary Venous Flow Pattern due to Left Ventricular Diastolic Dysfunction among Impaired Glucose Tolerance Patients

Bhuiyan, A. M., Hasan, K. M., Saha, P. P., Rahman, H. R., Sultana, Z., & Haq, M. T. (2020) · Journal of Current and Advance Medical Research · doi:10.3329/jcamr.v7i1.46422

Is nierfalen bij type-2- diabetes te voorkomen met angiotensine-II-receptorantagonisten?

(2002) · Medisch-Farmaceutische Mededelingen · doi:10.1007/bf03058043

Angiotensin-

System, J. O. R.-A.-A., Swift, P. A., Macgregor, G. A., Swift, P. A., & Macgregor, G. A. (2001)

Angiotensin-Receptor Blockers for Renal Protection in Type 2 Diabetes

Ruggenenti, P. L., Macia, M. L., & Remuzzi, G. (2006) · Aging Health · doi:10.2217/1745509x.2.2.295

Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy

(2005) · New England Journal of Medicine · doi:10.1056/nejm200504213521628 · Cited by 11 · see citing works

Renal and cardiovascular protection in type 2 diabetes mellitus: angiotensin II receptor blockers.

Deferrari, G., M., R., Deferrari, L., S., V., Ratto, E., & Parodi, D. (2002) · CINECA IRIS Institutial Research Information System (University of Genoa)

Inhibition of the renin-angiotensin system provides renoprotective effects for patients with type 2 diabetes mellitus

&NA; (2003) · Drugs & Therapy Perspectives · doi:10.2165/00042310-200319010-00006